So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

So-Young International Inc.NASDAQ: SY

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue falls 13.6% from a year ago

Deferred revenue stood at CN¥64.32M at the end of Q1 FY2026, down 13.6% from a year earlier and down 2.5% from the prior quarter. Over 3 fiscal years it compounded at +17.2% a year.

Context

  • Deferred revenue amounted to 2.4% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
  • Deferred revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps falling in the next quarterly balance sheet after a -13.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CN¥64.32M-2.5% QoQ
Last fiscal yearDec 2025
CN¥292.65M+53.7% YoY
Year agoMar 2025
CN¥74.42M-13.6% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.6%——
1 year+53.7%——
3-year CAGR+17.2%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

CNY · from the balance sheet

Latest · FY2025
292.65M CNY
Year-over-year change
+53.7%
4-year CAGR
+11.4%

Deferred Revenue vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred revenue is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -13.6% is the 5th highest of 7, against a peer median of +55.8%.
  • Deferred revenue amounts to 2.4% of total assets for SY, versus a peer median of 0.7%.
SY Competitors
Deferred Revenue for SY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYSo-Young International Inc.Mar 2026CN¥64.32M CNY-13.6%+17.2%2.4%
SOPHSOPHiA GENETICS S.A.Mar 2026$15.95M USD+62.1%+69.5%10.2%
VREXVarex Imaging CorporationApr 2026$14.5M USD+49.5%-2.9%1.3%
LABStandard BioTools Inc.Mar 2026$13.84M USD-20.1%+39.2%2.2%
SNDASonida Senior Living, Inc.Mar 2026$13.1M USD+104.6%+28.6%0.5%
SLPSimulations Plus, Inc.Feb 2026$5.53M USD+65.3%-2.0%3.8%
OMEROmeros CorporationMar 2026$2.82M USD——1.0%
LXRXLexicon Pharmaceuticals, Inc.Mar 2026$0 USD-100.0%—0.0%
CGEMCullinan Therapeutics, Inc.Mar 2026$0 USD——0.0%
ADCTADC Therapeutics S.A.Mar 2026$0 USD——0.0%
NMRANeumora Therapeutics, Inc. Common StockMar 2026$0 USD——0.0%
Peer median (excluding SY) —+55.8%+28.6%0.7%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.33B694.42M426.12M587.75M483.2M
Short-term Investments408.95M875.96M900.82M599.04M453.76M
Net Receivables110.45M170.29M80.38M226.25M68.65M
Inventory91.81M120.48M118.92M151.75M233.54M
Other Current Assets18.19M17.29M147.45M159.56M246.39M
Total Current Assets2.03B1.92B1.72B1.72B1.49B
Property, Plant & Equipment (Net)220.19M179.08M235.19M318.12M545.54M
Goodwill540.69M540.69M540.69M684K684.43K
Intangible Assets193.96M169.28M145.25M126.62M144.19M
Long-term Investments252.5M227.96M261.02M280.28M274.93M
Tax Assets47.52M64.74M78.03M84.95M69.36M
Other Non-current Assets48.1M99.29M310.49M285.1M131.08M
Total Non-current Assets1.3B1.28B1.49B1.01B1.17B
Total Assets3.33B3.2B3.21B2.74B2.65B
Account Payables00000
Short-term Debt0029.83M69.77M39.81M
Tax Payables48.57M74.58M56.89M00
Deferred Revenue190.26M181.67M195.21M190.37M292.65M
Other Current Liabilities256.23M239.93M288.77M(119.6M)276.34M
Total Current Liabilities712.4M538.04M540.42M630.21M784.55M
Long-term Debt00000
Deferred Tax Liabilities38.58M30.99M25.08M19.76M10.62M
Deferred Revenue (Non-current)(38.58M)0000
Other Non-current Liabilities38.58M30.99M1.54M1.26M2.78M
Total Non-current Liabilities100.93M51.97M112.83M146.22M196.89M
Total Liabilities813.33M590.01M653.25M776.43M981.44M
Common Stock267K273K275K290K294.19K
Retained Earnings(272.37M)(346.62M)(330.17M)(885.84M)(1.18B)
Accumulated OCI(63.56M)33.13M52.04M31.56M59.83M
Other Stockholders Equity00000
Minority Interest70.85M109.94M117.19M119.61M115.58M
Total Equity2.52B2.61B2.56B1.96B1.67B
Total Debt105.89M71.26M145.77M239.88M299.9M
Net Debt(1.23B)(623.16M)(280.35M)(347.87M)(183.3M)

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.